Verana Health launched a real-world dataset for patients with uveitic macular edema, according to a press release.
The Qdata uveitic macular edema (UME) module contains information on more than 152,000 de-identified patients with an average of about 4 years of follow-up, including variables such as visual acuity, central subfield thickness and IOP.
The goal of the dataset is to aid in clinical development, health economics and outcomes research, as well as other efforts to address uveitic macular edema.
“Key variables such as visual acuity, central subfield thickness and intraocular